Singulair is a prescription medication used to manage certain respiratory conditions. It contains montelukast as its active ingredient and is supplied as a pill in strengths of 4 mg, 5 mg, and 10 mg. Montelukast belongs to the class of leukotriene receptor antagonists, which are part of the broader respiratory health therapeutic category. In Hong Kong, Singulair is regulated by the Department of Health and is available only with a medical prescription.
Montelukast blocks the action of leukotrienes, inflammatory molecules that are released in response to allergens and other triggers. By binding to the cysteinyl-leukotriene receptor 1 (CysLT₁) on airway smooth-muscle cells, it prevents bronchoconstriction, mucus production, and airway edema. The effect begins within a few hours after the first dose, with steady-state plasma concentrations reached after 3 days of once-daily dosing. This mechanism helps keep the airways open and reduces symptoms of asthma and allergic rhinitis.
Singulair is approved by regulatory authorities for the following indications:
In Hong Kong, these uses are listed on the product label and are supported by clinical guidelines from local respiratory societies.
Research has shown that montelukast can improve symptoms of chronic idiopathic urticaria (CIU). Randomized controlled trials demonstrated a reduction in wheal and flare responses when montelukast is added to standard antihistamine therapy. Although CIU is not an approved indication for Singulair in Hong Kong, clinicians may consider it off-label for patients who do not achieve adequate control with antihistamines alone.
Off-label use requires medical supervision and individualized risk assessment.
Patients with active liver disease or those who have experienced mood changes while on leukotriene antagonists should discuss alternatives with their healthcare provider.
Routine laboratory tests are not required for most patients on Singulair. However, clinicians should:
This article provides educational information about Singulair and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Yes. Because Singulair is taken once daily in the evening, you can maintain the same dosing time after adjusting to the local evening. If the time shift is extreme, discuss a short-term adjustment with your provider to avoid missed doses.
The 10 mg tablet commonly bears the imprint “M10 S” on one side and “M10” on the other. The lower-strength tablets have distinct imprints (e.g., “M4” for 4 mg). The imprint helps confirm authenticity and identify the dosage.
Montelukast is not listed as a prohibited substance by the World Anti-Doping Agency (WADA). Athletes generally do not need a therapeutic use exemption for Singulair, but they should verify the latest regulations of their governing body.
Singulair is listed on the Hong Kong Hospital Authority’s formulary for chronic asthma and allergic rhinitis. Eligibility for subsidized supply depends on clinical assessment and physician prescription within the public system.
Inhaled corticosteroids are first-line controller therapy for most asthma patients. Singulair is an add-on or alternative for patients who cannot tolerate inhaled steroids or prefer an oral option. Both improve control, but inhaled steroids have stronger anti-inflammatory effects.
Yes. Montelukast and antihistamines act via different pathways and are commonly prescribed together for better relief of allergic rhinitis symptoms. No major pharmacokinetic interaction has been reported.
Report any new depression, anxiety, or suicidal thoughts to your healthcare provider immediately. The provider may reassess the risk-benefit balance and consider alternative therapy if needed.
Missing multiple consecutive doses can lead to loss of asthma or allergy control. If you have missed more than two days, restart the regular evening dosing schedule and contact your provider if symptoms worsen.
No. Singulair tablets should be stored at room temperature, protected from excessive heat and moisture. Refrigeration is unnecessary and may affect tablet integrity.
Singulair is a maintenance drug and does not provide rapid relief. For acute symptoms, always use a short-acting bronchodilator (e.g., albuterol) as prescribed by your physician.
